FDA - Tobacco Products: Principles for Designing and Conducting Tobacco Product Perception and Intention Studies

August 25, 2022

FDA - Tobacco Products: Principles for Designing and Conducting Tobacco Product Perception and Intention Studies.

August 2022

This final guidance is intended to help applicants (or “you”) design and conduct tobacco product perception and intention (TPPI) studies that may be submitted as part of a modified risk tobacco product application (MRTPA), a premarket tobacco product application (PMTA), or a substantial equivalence report (SE Report). TPPI studies are studies that can be used to assess, among other things, individuals’ perceptions of tobacco products, understanding of tobacco product information (e.g., labeling, modified risk information), and intentions to use tobacco products. It is possible for a TPPI study to also include an actual use component (e.g., an actual product utilized in a simulated use setting or a real environment of use); however, a discussion of actual use research is beyond the scope of this final guidance. This final guidance addresses the following scientific issues for applicants to consider as they design and conduct TPPI studies to support tobacco product applications:

  • Developing TPPI study aims and hypotheses
  • Designing quantitative and qualitative TPPI studies
  • Selecting and adapting measures of TPPI study constructs
  • Determining TPPI study outcomes
  • Selecting and justifying TPPI study samples
  • Analyzing TPPI study results

Download the Final Guidance Document

FINAL

Read the Federal Register Notice

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs.




Agency Alerts General Regulatory

August 25, 2022

Recently Released Final Rule Extends FDA’s Authority to ALL Tobacco Products

On May 5, 2016, the FDA published a final rule, extending the Agency’s authority to all tobacco products, including, but not limited to, e-cigarettes, cigars, and hookah and pipe tobacco.  This rule,...

Read More
Agency Alerts General Regulatory

August 25, 2022

FDA Updates Requirements Regarding Health Document Submissions for Tobacco Products

On Friday, September 9th, FDA announced the availability of a revised draft guidance, entitled “Health Document Submission Requirements for Tobacco Products.”  The document was initially published in...

Read More
Agency Alerts General Regulatory

August 25, 2022

FDA Releases Draft Guidance Regarding the Use of Investigational Tobacco Products

Currently, there are no regulations specifically regarding investigational tobacco products. As such, at this time they are not exempt from requirements stated in the FD&C Act. Last week, FDA...

Read More